Pharmaxis Ltd (AU:SNT) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Syntara Limited has announced the cessation of 350,700 performance rights due to the non-fulfillment of conditions required for their vesting. The securities lapsed as the prescribed conditions were either not met or became impossible to satisfy as of November 23, 2022. This could potentially interest investors who track company performance and changes in issued capital.
For further insights into AU:SNT stock, check out TipRanks’ Stock Analysis page.